VENTURE CAPITAL POST

The US Food and Drug Administration (FDA) has approved Madrigal Pharmaceuticals' Rezdiffra, the first drug to treat serious liver disease.

Oprah Winfrey's announcement that she was leaving WeightWatchers International, Inc.'s board has made the company's shares tumbling.

The Therapeutic Goods Administration (TGA) of Australia seeks suggestions after it announced its plan to adopt new EMA guidelines. Said guidelines include clinical development of drugs against Duchenne Muscular Dystrophy (DMD). TGA will accept comments until 9 November.

Some states in Australia already legalized medicinal marijuana regionally, but the new bill will allow marijuana to be cultivated and consumed for medical purposes across the country. The bill is highly likely to become a law because it has received huge supports from the authorities and citizens.

Allergan Inc became US$9.6 billion cheaper for acquirers who would want to purchase the Botox wrinkle treatment.

Heptares Therapeutics raised $21 million from Stanley Family Foundation and other investors.

Shire Plc (SHP) pulled off a settlement agreement with Teva Pharmaceutical Industries Ltd. (TEVA), enabling the later to manufacture cheap generic copies of Intuniv.

Bayer AG is predicting that its Xarelto, a drug to prevent stroke, will reach peak annual sales.